GABAB receptor ligands do not modify conditioned fear responses in BALB/c mice

Behavioural Brain Research

Volumn 256, Issue , 2013, Pages 151-156

  Sweeney, Fabian F ^a   O'Leary, Olivia F ^a   Cryan, John F ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Anxiety; BALB c; Fear Conditioning; GABAB

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; [3 (3,4 DICHLOROBENZYLAMINO)PROPYL](DIETHOXYMETHYL)PHOSPHINIC ACID; N,N' DICYCLOPENTYL 2 METHYLTHIO 5 NITRO 4,6 PYRIMIDINEDIAMINE; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; BENZYLAMINE DERIVATIVE; CYCLOPENTANE DERIVATIVE; N,N'-DICYCLOPENTYL-2-METHYLSULFANYL-5-NITRO-PYRIMIDINE-4,6-DIAMINE; PHOSPHINIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; CONDITIONING; CONTROLLED STUDY; FEAR; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECALL; REINFORCEMENT; TRANQUILIZING ACTIVITY; ANIMAL; ANXIETY; AUDITORY STIMULATION; CATALEPSY; CONDITIONED REFLEX; DRUG EFFECTS; DRUG THERAPY; ELECTRIC SHOCK; ETIOLOGY; PHOTOSTIMULATION;

ACOUSTIC STIMULATION; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BENZYLAMINES; CONDITIONING, CLASSICAL; CYCLOPENTANES; ELECTROSHOCK; EXTINCTION, PSYCHOLOGICAL; FEAR; FREEZING REACTION, CATALEPTIC; GABA MODULATORS; GABA-B RECEPTOR ANTAGONISTS; MALE; MENTAL RECALL; MICE, INBRED BALB C; PHOSPHINIC ACIDS; PHOTIC STIMULATION; PYRIMIDINES;

EID: 84883354409     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.035     Document Type: Article

References (25)

1. Cryan J.F., Kaupmann K. Don't worry B happy!: a role for GABA(B) receptors in anxiety and depression. Trends in Pharmacological Sciences 2005, 26:36-43.
2. Mombereau C., Kaupmann K., van der Putten H., Cryan J.F. Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors. European Journal of Pharmacology 2004, 497:119-120.
3. Mombereau C., Kaupmann K., Gassmann M., Bettler B., van der Putten H., Cryan J.F. Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport 2005, 16:307-310.
4. Partyka A., Kłodzińska A., Szewczyk B., Wierońska J.M., Chojnacka-Wójcik E., Librowski T., et al. Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior. Pharmacological Reports 2007, 59:757-762.
5. Frankowska M., Filip M., Przegaliński E. Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacological Reports 2007, 59:645-655.
6. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., Cryan J.F. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 2004, 29:1050-1062.
7. Cryan J.F., Sweeney F.F. The age of anxiety: role of animal models of anxiolytic action in drug discovery. British Journal of Pharmacology 2011, 164:1129-1161.
8. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neuroscience and Biobehavioral Reviews 1999, 23:743-760.
9. Johansen J.P., Cain C.K., Ostroff L.E., LeDoux J.E. Molecular mechanisms of fear learning and memory. Cell 2011, 147:509-524.
10. Wilensky A.E., Schafe G.E., LeDoux J.E. Functional inactivation of the amygdala before but not after auditory fear conditioning prevents memory formation. Journal of Neuroscience 1999, 19:RC48.
11. Heaney C.F., Bolton M.M., Murtishaw A.S., Sabbagh J.J., Magcalas C.M., Kinney J.W. Baclofen administration alters fear extinction and GABAergic protein levels. Neurobiology of Learning and Memory 2012, 98:261-271.
12. Schuler V., Lüscher C., Blanchet C., Klix N., Sansig G., Klebs K., et al. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 2001, 31:47-58.
13. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behavioural Brain Research 2001, 125:141-149.
14. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:16050-16055.
15. Brinks V., de Kloet E.R., Oitzl M.S. Corticosterone facilitates extinction of fear memory in BALB/c mice but strengthens cue related fear in C57BL/6 mice. Experimental Neurology 2009, 216:375-382.
16. Felice D., O'Leary O.F., Pizzo R.C., Cryan J.F. Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action. Neuropharmacology 2012, 63:1380-1388.
17. Shaban H., Humeau Y., Herry C., Cassasus G., Shigemoto R., Ciocchi S., et al. Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition. Nature Neuroscience 2006, 9:1028-1035.
18. Pan B-X., Dong Y., Ito W., Yanagawa Y., Shigemoto R., Morozov A. Selective gating of glutamatergic inputs to excitatory neurons of amygdala by presynaptic GABAb receptor. Neuron 2009, 61:917-929.
19. Li X., Risbrough V.B., Cates-Gatto C., Kaczanowska K., Finn M.G., Roberts A.J., et al. Comparison of the effects of the GABA(B) receptor positive modulator BHF177 and the GABA(B) receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. Neuropharmacology 2013, 70C:156-167.
20. Mondadori C., Jaekel J., Preiswerk G. CGP 36742: the first orally active GABAB blocker improves the cognitive performance of mice, rats, and rhesus monkeys. Behavioral and Neural Biology 1993, 60:62-68.
21. Helm K.A., Haberman R.P., Dean S.L., Hoyt E.C., Melcher T., Lund P.K., et al. GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus. Neuropharmacology 2005, 48:956-964.
22. Arai S., Takuma K., Mizoguchi H., Ibi D., Nagai T., Kamei H., et al. GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice. European Journal of Pharmacology 2009, 602:101-104.
23. Cryan J.F., Kelly P.H., Chaperon F., Gentsch C., Mombereau C., Lingenhoehl K., et al. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. Journal of Pharmacology and Experimental Therapeutics 2004, 310:952-963.
24. Jacobson L.H., Kelly P.H., Bettler B., Kaupmann K., Cryan J.F. Specific roles of GABA(B(1)) receptor isoforms in cognition. Behavioural Brain Research 2007, 181:158-162.
25. Paterson N.E., Hanania T. The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation. Behavioural Brain Research 2010, 208:258-264.